Logo
info@sanotize.com

Blog Details

Business Insider

SaNOtize Research and Development Corporation today announced it enrolled its first participant on May 12, 2020 in a multi-centre Phase II trial of its Nitric Oxide Releasing Solution (NORSTM) for the prevention and early treatment of COVID-19.

SaNOtize Phase II COVID Prevention and Treatment Trial Underway in BC, Quebec Enrolment to Begin June 1

SaNOtize Phase II COVID Prevention and Treatment Trial Underway

Adminmaster

1-855-357-7398
info@sanotize.com
Twitter Linkedin

Explore

Important Information

This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug or medical device including the ones under development on this web site.

Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.

This website is intended to educate our investors and potential business partners, and is not intended as marketing of any specific products.